VNO
63
4
UNH
42
-13
WRK
65
9
RL
72
3
RRC
75
2
M
36
2
CMCSA
48
-2
GLW
61
2
PM
47
2
TRIP
70
-3
TEL
75
7
STI
55
-8
TRV
43
-2
BXP
52
3
NVDA
60
-9
AEP
42
2
NRG
77
2
QCOM
73
2
T
45
7
CCI
33
2
VNO
63
4
UNH
42
-13
WRK
65
9
RL
72
3
RRC
75
2
M
36
2
CMCSA
48
-2
GLW
61
2
PM
47
2
TRIP
70
-3
TEL
75
7
STI
55
-8
TRV
43
-2
BXP
52
3
NVDA
60
-9
AEP
42
2
NRG
77
2
QCOM
73
2
T
45
7
CCI
33
2
Financhill
Back

UroGen Pharma Stock Predictions

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.
Buy
53

URGN
UroGen Pharma

Last Price:
13.93
Seasonality Move:
-7.76%

7 Day Trial

ALL ACCESS PASS

$ 7

He cracked the code to crypto

Now he says a new two-year bull market has begun. And he likes one altcoin above all others.

UroGen Pharma Stock Forecast

  • Over the next 52 weeks, UroGen Pharma has on average historically fallen by 12.1% based on the past 6 years of stock performance.
  • UroGen Pharma has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is UroGen Pharma Stock Undervalued?
    The current UroGen Pharma [URGN] share price is $14.04. The Score for URGN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • URGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will UroGen Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, UroGen Pharma has on average historically fallen by 12.1% based on the past 6 years of stock performance.

UroGen Pharma Stock Rating

Buy
53
UroGen Pharma (URGN) is a Buy

Is UroGen Pharma overpriced?

  • UroGen Pharma has fallen lower in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

UroGen Pharma Stock Price History

Is URGN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
urogen.com

52-Week Data

52-Week High:
24.13
52-Week Low:
8.69

Prediction Charts

Market Cap:
479.07M
Price in USD:
14.04
Volume:
198.39K
Beta:
1.13

Technical Analysis

SMA50:
15.69
SMA100:
15.55
SMA200:
15.19
52-Wk Change:
21.14%

Stock Predictions

  • Is UroGen Pharma stock public?
    Yes, UroGen Pharma is a publicly traded company.
  • What is the UroGen Pharma stock quote today?
    The UroGen Pharma stock price is 14.04 USD today.
  • How to buy UroGen Pharma stock online?
    You can buy UroGen Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-10 13.20 12.93 13.20 12.58
Apr-11 13.14 13.22 13.23 12.37
Apr-12 13.09 15.14 15.21 13.00
Apr-15 15.32 15.10 15.50 14.21
Apr-16 14.86 14.52 15.05 14.15
Apr-17 14.61 14.25 14.66 14.02
Apr-18 14.36 14.27 14.54 13.96
Apr-19 14.06 13.75 14.28 13.17
Apr-22 13.80 14.37 14.52 13.58
Apr-23 14.40 14.52 14.85 14.11
Apr-24 14.66 14.21 14.76 14.19
Apr-25 14.05 13.82 14.50 13.77
Apr-26 13.97 14.15 14.32 13.69
Apr-29 14.22 14.04 14.68 13.92

UroGen Pharma Earnings

UroGen Pharma Earnings Report: Per Share UroGen Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

UroGen Pharma Forecast Revenue Growth

UroGen Pharma Stock Analysis: Historical quarterly revenues per share for UroGen Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.06 per share, and an increase next year of $1.71 per share.

* UroGen Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.